Boston Scientific CEO Mike Mahoney is bullish on the company's Watchman anti-stroke device, saying he wants to double the number of hospitals offering the treatment beginning in the 3rd quarter.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DJJYM6
Cap comentari:
Publica un comentari a l'entrada